Male fertility startup Legacy scored $25 million in a Sequence B funding spherical led by Bain Capital Ventures.
Different buyers collaborating within the increase embody FirstMark Capital, Part 32 and TQ Ventures and Valor Fairness Companions.
WHAT IT DOES
The male fertility startup affords at-home sperm testing kits, semen evaluation and cryopreservation. Customers can order a check on-line and have it delivered to their houses, the place they gather a pattern and schedule a pickup for evaluation.
Legacy checks the pattern and offers a report, together with way of life suggestions. Clients can arrange telehealth appointments with clinicians to debate outcomes and subsequent steps.
“Bringing life into this world is likely one of the best joys folks can expertise of their lifetime, however household planning will be daunting – and at instances feels hopeless,” CEO and founder Khaled Kteily mentioned in a press release. “Our objective is to get rid of the ache factors concerned, make the expertise human, fairly than scientific, and assist everybody create the households they need when they need.”
WHAT IT’S FOR
With the Sequence B, Legacy plans to double its variety of staff and broaden its choices past testing, preservation and fertility help.
It would additionally launch a brand new effort, dubbed Legacy Labs. The corporate mentioned the bodily labs will enable for same-day, at-home service geared towards clients who’re planning surgical procedures or remedies that will have an effect on fertility and have to protect sperm extra rapidly, like most cancers sufferers.
Fertility and reproductive companies are a rising market, although many choices are targeted on feminine fertility. Extra employers are additionally together with fertility care as a benefit for his or her staff.
One other participant growing its deal with the fertility area is direct-to-consumer digital care firm Ro, which in March introduced it had acquired male fertility startup Dadi. A couple of 12 months in the past, Ro additionally acquired one other fertility and reproductive health-focused company, Modern Fertility.
In February, hybrid fertility firm Kindbody announced plans to acquire Vios Fertility Institute, a community of fertility clinics. In the meantime, Proov, one other fertility testing startup, introduced it had scooped up $9.7 million in Series A funding in December.